Gary Ingenito

Companies

• Catalyst PharmaceuticalsChief Medical Officer Jul 7, 2015 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Catalyst Pharmaceuticals CPRX68,873 shares²May 14, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2025Sold 44,000 shares at $23.63 of Catalyst Pharmaceuticals²
• May 14, 2025Exercised options 44,000 shares at $4.64 of Catalyst Pharmaceuticals²
• May 13, 2025Sold 200,000 shares at $23.68 of Catalyst Pharmaceuticals²
• May 13, 2025Exercised options 200,000 shares at $3.42 of Catalyst Pharmaceuticals²
• Mar 6, 2025Sold 180,096 shares at $21.67 of Catalyst Pharmaceuticals³
• Mar 6, 2025Exercised options 180,096 shares at $2.24 of Catalyst Pharmaceuticals³
• Mar 5, 2025Sold 44,904 shares at $22.09 of Catalyst Pharmaceuticals³
• Mar 5, 2025Exercised options 44,904 shares at $2.24 of Catalyst Pharmaceuticals³
• Feb 14, 2025Shares withheld for tax 2,435 shares of Catalyst Pharmaceuticals⁴
• Feb 14, 2025Exercised options 10,000 shares of Catalyst Pharmaceuticals⁴
• Dec 27, 2024Shares withheld for tax 3,541 shares of Catalyst Pharmaceuticals⁵
• Dec 27, 2024Exercised options 9,000 shares of Catalyst Pharmaceuticals⁵
• Dec 9, 2024Shares withheld for tax 2,891 shares of Catalyst Pharmaceuticals⁶
• Dec 9, 2024Exercised options 7,349 shares of Catalyst Pharmaceuticals⁶
• Nov 27, 2024Sold 3,369 shares at $22.67 of Catalyst Pharmaceuticals⁷
• Nov 27, 2024Sold 8,631 shares at $22.74 of Catalyst Pharmaceuticals⁷
• Nov 27, 2024Exercised options 12,000 shares at $4.01 of Catalyst Pharmaceuticals⁷
• Nov 20, 2024Sold 38,000 shares at $21.20 of Catalyst Pharmaceuticals⁸
• Nov 20, 2024Exercised options 38,000 shares at $4.01 of Catalyst Pharmaceuticals⁸
• Aug 9, 2024Sold 100,000 shares at $18.04 of Catalyst Pharmaceuticals⁹
• Aug 9, 2024Exercised options 100,000 shares at $4.01 of Catalyst Pharmaceuticals⁹
• Jun 5, 2024Sold 80,000 shares at $16.16 of Catalyst Pharmaceuticals¹⁰
• Jun 5, 2024Exercised options 80,000 shares at $4.01 of Catalyst Pharmaceuticals¹⁰
• Feb 15, 2024Shares withheld for tax 2,435 shares of Catalyst Pharmaceuticals¹¹
• Feb 15, 2024Exercised options 10,000 shares of Catalyst Pharmaceuticals¹¹